| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP And CFO | SVP And CFO
1 company
Martin Samuel Bates is a SVP And CFO at Celldex Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | CLDX Celldex Therapeutics, Inc. | SVP And CFO | Sale+OE | 17,172 | $35.42 | $608,314.67 | -37.9% | +20.4% | -38.7% | |
| May 30, 2024 | CLDX Celldex Therapeutics, Inc. | SVP And CFO | Sale+OE | 35,000 | $34.05 | $1,191,774.50 | -58.2% | +14.4% | -41.2% | |
| Aug 12, 2022 | CLDX Celldex Therapeutics, Inc. | SVP And CFO | Sale+OE | 20,000 | $36.52 | $730,485.09 | -16.4% | +1.3% | -19.0% | |
| Dec 23, 2021 | CLDX Celldex Therapeutics, Inc. | SVP And CFO | Sale+OE | 9,500 | $42.00 | $399,000.00 | -28.0% | -19.5% | +5.0% | |
| Nov 15, 2021 | CLDX Celldex Therapeutics, Inc. | SVP And CFO | Sale+OE | 9,500 | $43.57 | $413,883.36 | -14.5% | -26.4% | -14.7% | |
| Aug 10, 2021 | CLDX Celldex Therapeutics, Inc. | SVP And CFO | Sale+OE | 2,738 | $45.25 | $123,894.50 | -5.4% | -2.3% | -19.7% | |
| Jun 9, 2020 | CLDX Celldex Therapeutics, Inc. | SVP And CFO | Buy | 9,750 | $3.05 | $29,737.50 | +989.8% | - | - |